ASPR/HHS Test to Treat Program

 

To: Residential Care Facilities and Long-term care pharmacies   From: CDPHE Therapeutics Team We are reaching out today to ask for your help in encouraging providers to participate in the ASPR/HHS Test to Treat program to help us protect those most at-risk from COVID-19. Test -to-Treat allows providers to enroll as "full-service" therapeutics providers: from COVID-19 testing and symptom screening to prescribing and dispensing oral antivirals (OAVs). Because OAVs are most effective when started within five days of COVID onset, this program seeks to simplify the process of receiving treatment for high-risk populations, such as residents of long-term care facilities. While the Test to Treat program is likely to expand to include additional facility types, this first wave focuses on long-term care facilities, combined clinics/pharmacies, and federally qualified health centers. These providers will now be able to order OAVs (Paxlovid and Molnupiravir) directly through the federal government, rather than relying on state and Tribal allocation cycles.   HHS requires prospective Test to Treat providers meet the following criteria: Sites must be able to provide comprehensive end-to-end testing and treatment services to support a seamless patient experience, including: COVID-19 testing onsite (or evaluation of at-home testing). Linkage to a clinical evaluation by a licensed health care provider after a positive COVID-19 test to provide prescriptions when appropriate. Co-located or affiliated outpatient pharmacy that is able to readily dispense medications. Sites must be able to provide these services, regardless of insurance status, same-day or next day. Sites can partner with another provider or pharmacy to offer these services. Residential care facilities can partner with long-term care pharmacies or other groups to meet these requirements. If you know of any facility that is a good fit for this program, email Megan Ramsey Kolli at megan.ramseykolli@state.co.us.  To learn more about the Test to Treat program, read ASPR’s LTCF Distribution Plan and Provider FAQs.